Astera Labs (NASDAQ:ALAB) CFO Sells $1,485,843.81 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the sale, the chief financial officer owned 192,083 shares in the company, valued at approximately $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Astera Labs Stock Performance

Shares of ALAB opened at $129.68 on Friday. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The stock’s 50-day simple moving average is $160.40 and its 200 day simple moving average is $174.33. The stock has a market capitalization of $21.90 billion, a price-to-earnings ratio of 106.30, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the prior year, the business posted $0.37 earnings per share. The company’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on ALAB shares. Morgan Stanley restated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. BNP Paribas Exane initiated coverage on Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating on the stock. Barclays set a $165.00 price target on Astera Labs in a research report on Thursday, January 15th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $192.89.

Hedge Funds Weigh In On Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the company. Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Astera Labs by 21.6% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Astera Labs by 94.6% during the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock worth $9,908,000 after acquiring an additional 53,276 shares during the last quarter. Harbour Investments Inc. increased its stake in Astera Labs by 207.7% in the 2nd quarter. Harbour Investments Inc. now owns 2,446 shares of the company’s stock worth $221,000 after purchasing an additional 1,651 shares during the period. Bank of New York Mellon Corp lifted its position in Astera Labs by 34.5% in the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock valued at $47,208,000 after purchasing an additional 133,961 shares during the last quarter. Finally, Corient Private Wealth LLC purchased a new stake in shares of Astera Labs during the second quarter valued at approximately $543,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
• Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
• Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
• Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
• Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
• Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
• Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
• Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.